The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen research
This ethnographic case study of psychedelic research examines the role of first-person subjective experience for researchers and how it influences their paradigm in theory and practice. Langlitz found that while researchers maintain an objectivist façade that maintains the primacy of psychopharmacological techniques such as neuroimaging, most researchers believe that psychedelics can not be explained in pharmacological terms alone, but also depends on set and setting. Therefore, the author urges reconciliation between the fields of psychopharmacology and the human sciences.
Abstract
The elimination of subjectivity through brain research and the replacement of so-called ‘folk psychology’ by a neuroscientifically enlightened worldview and self-conception has been both hoped for and feared. But this cultural revolution is still pending. Based on nine months of fieldwork on the revival of hallucinogen research since the ‘Decade of the Brain,’ this paper examines how subjective experience appears as epistemic object and practical problem in a psychopharmacological laboratory. In the quest for neural correlates of (drug-induced altered states of) consciousness, introspective accounts of test subjects play a crucial role in neuroimaging studies. Firsthand knowledge of the drugs’ flamboyant effects provides researchers with a personal knowledge not communicated in scientific publications, but key to the conduct of their experiments. In many cases, the ‘psychedelic experience’ draws scientists into the field and continues to inspire their self-image and way of life. By exploring these domains the paper points to a persistence of the subjective in contemporary neuropsychopharmacology.
Research Summary of 'The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen research'
Introduction
Langlitz opens by situating contemporary hallucinogen research at the intersection of neuroscience and questions about the status of subjective experience. The paper contrasts eliminative materialist claims—that neuroscientific accounts render subjective reports illusory—with the empirical practices of psychopharmacology, arguing that subjective experience remains a persistent epistemic object rather than being simply eradicated by brain imaging and neurochemistry. Ethnographic vignettes from the laboratories of prominent researchers are used to frame a philosophical puzzle: how do first-person reports and neurophysiological measurements relate when both are invoked to study altered states induced by substances such as psilocybin and ketamine? The study sets out to explore how subjectivity figures in laboratory practice rather than to test a causal hypothesis. Through ethnographic observation and interviews in European psychopharmacology labs, Langlitz examines three domains in which subjectivity persists: as data (introspective self-reports used alongside neuroimaging), as the personal experience of scientists themselves, and as a culturally mediated form of experience that shapes both experimental outcomes and researchers' self-conceptions. The paper treats hallucinogen research as a case study to illuminate broader tensions between objectivist ideals and the lived practices of cognitive neuroscience.
Expert Research Summaries
Go Pro to access AI-powered section-by-section summaries, editorial takes, and the full research toolkit.
Full Text PDF
Full Paper PDF
Create a free account to open full-text PDFs.
Study Details
- Study Typemeta
- Journal
- Topics
- APA Citation
Langlitz, N. (2010). The persistence of the subjective in neuropsychopharmacology: observations of contemporary hallucinogen research. History of the Human Sciences, 23(1), 37-57. https://doi.org/10.1177/0952695109352413
References (3)
Papers cited by this study that are also in Blossom
Leary, T., Litwin, G. H., Metzner, R. · Journal of Nervous and Mental Disease (1977)
Sessa, B. · Journal of Psychopharmacology (2008)
Vollenweider, F. X., Leenders, K. L., Maguire, P. et al. · Neuropsychopharmacology (1997)
Cited By (4)
Papers in Blossom that reference this study
Smigielski, L., Kometer, M., Scheidegger, M. et al. · Scientific Reports (2019)
Majic, T., Schmidt, T. T., Gallinat, J. · Journal of Clinical Psychopharmacology (2015)
Nutt, D. J., Carhart-Harris, R. L. · Current Drug Abuse Reviews (2015)
Studerus, E., Gamma, A., Kometer, M. et al. · PLOS ONE (2012)
Your Personal Research Library
Go Pro to save papers, add notes, rate studies, and organize your research into custom shelves.